Additional file 10: of Effects of novel HDAC inhibitors on urothelial carcinoma cells

Aline Kaletsch (5576153); Ananda Jaguva Vasudevan (3422579); Chenyin Wang (5576156); Christoph Gertzen (5576162); Constanze Wiek (140463); Finn Hansen (5576159); Günter Niegisch (3449342); Helmut Hanenberg (140467); Holger Gohlke (525601); Maria Pinkerneil (3613667); Matthias Kassack (2160217); Michèle Hoffmann (3449339); Thomas Kurz (1648405); Wolfgang Schulz (3449312)

Additional file 10: of Effects of novel HDAC inhibitors on urothelial carcinoma cells

Authors: Aline Kaletsch (5576153)
Ananda Jaguva Vasudevan (3422579)
Chenyin Wang (5576156)
Christoph Gertzen (5576162)
Constanze Wiek (140463)
Finn Hansen (5576159)
Günter Niegisch (3449342)
Helmut Hanenberg (140467)
Holger Gohlke (525601)
Maria Pinkerneil (3613667)
Matthias Kassack (2160217)
Michèle Hoffmann (3449339)
Thomas Kurz (1648405)
Wolfgang Schulz (3449312)
Publication date
Publisher
Doi

Abstract

Figure S7. Effects of treatment with 19i on primary normal urothelial cells using High Content Analysis-based fluorescent live/dead assay. Percentage of control cell counts of primary urothelial cells (culture # UP281) after 72 h treatment with TMP269 using High Content Analysis-based fluorescent live/dead assay. Data shown are mean from n = 3. (JPG 1137 kb

Similar works

Full text

Available Versions

FigShare

oai:figshare.com:article/68853...

Last time updated on 13/08/2018